Imaging Station

Investigating meniscus-assisted solution printing of large-grained perovskite film for high-efficiency solar cells

LTS420

Solution printing is a novel technique which uses an ink solution, containing semi-conductor precursors or nanoparticles, and deposits these on substrates with desirable characteristics. This offers a cost-effective method of creating large area thin film optoelectronics whilst also offering precise control over the stoichiometry and adaptability of the material. Metal halide perovskites have superb optoelectronic properties and the last few years has seen their power conversion efficiency increase rapidly, largely through the optimisation of the crystal morphology. 

The requirement to control morphology has posed a problem for solution printing. The understanding of crystallisation in dynamic flow of perovskite inks is quite limited, thus imposing restrictions in achieving high-quality perovskite films by the solution-printing technique.

A group from the Georgia Institute of Technology and the University of Nebraska-Lincoln in the USA used a meniscus-assisted solution printing method to elucidate the crystallisation kinetics of perovskite inks and help create high efficiency perovskite solar cells. The thin-films were created with preferred crystal orientation with micrometre-scale grains. 

When discussing their work Professor Lin said, “Through integrating the meniscus effect within the solution printing, we found that the solvent evaporation could be largely promoted by the meniscus effect instead of the thermal evaporation as in conventional doctor-blade coatings, thus leading to the low-temperature solution-based deposition of high-quality perovskite films with preferred crystal orientations. This low temperature feature circumvents thermal degradations and thermomechanical fatigues on perovskite and electrode materials, as well as decreases energy consumptions. Our technique paves the pathway for depositing perovskite thin films on flexible polymer substrates, and is anticipated to promote the future development and applications of perovskites in low-cost, large-area, and flexible optoelectronic devices.”

The group used an LTS350*, now superseded by the LTS420 to control the substrate temperature during the meniscus-assisted solution printing process, due to its capability of precisely controlling the temperature at ±0.1oC. Their investigation on the crystallisation kinetics of perovskite films revealed that a large temperature fluctuation would seriously impact the crystallisation kinetics of perovskite films during the meniscus-assisted printing process. The LTS350* was ideal for maintaining the substrate at a constant temperature and focusing on the exploration of the meniscus effect on the perovskite crystallisation process. 

Their study helped to uncover the crystallisation kinetics of perovskites during the printing process, providing rational guides to precisely control the crystallisation morphology of printed perovskite films. By improving the control over morphology, the group’s work helps to pave a route to large-area optoelectronic devices for commercial applications.

*The LTS350 has been superseded by the LTS420 offering a large temperature range and better temperature control to 0.01°C.

Read the research paper here

An immortalised adult human erythoid line facilitates sustainable and scalable generation of functional red cells

CSS450 shown above

Medical advancements in the last few decades have seen the average human life expectancy notably increase. However, despite improved medical techniques and procedures, the demand for blood is ever increasing. Donated blood is in short supply and has a limited shelf life while current in-vitro methods of culturing do not provide a sustainable supply suitable for clinical needs. 

Trakarnsanga et al., discovered a method of creating an immortal red blood cell (RBC) supply. Through testing these RBCs have been shown to be molecularly and functionally similar to in vitro cultured RBCs. 

Stem cells are cells which are capable of proliferating into many - and sometimes all - types of cells. Previous in-vitro methods of culturing RBCs used the differentiating abilities of stem cells to produce RBCs from adult peripheral blood or umbilical cord blood stem cells. However, these RBCs have limited proliferation capacity and cells derived from cord blood often show fetal phenotypes. 

Trakarnsanga et al., produced the BEL-A (Bristol Erythroid Line Adult) line which was created through transducing early erythroid cells grown from adult bone marrow stem cells with a plasmid construct. Environmental control maintained these erythroid cells in an indefinitely proliferative state. The cultured cells could then be induced to complete maturation through removal of the inducing factor. The bloodgroup of the cultured RBC matched that of the cell donor while the protein expression profiles of these cells were found to be similar to in-vitro cultured RBCs. 

RBCs must be able to change shape under the stress of mechanical forces without rupturing. Testing this property in the BEL-A line is vital for clinical use. The group used the CSS450 shear stage, Imaging Station and Linkam imaging and control software to test the deformability of the cultured cells. The BEL-A line bound oxygen and had deformability indexes comparable to normal RBCs. 

Transplantation of the BEL-A line into a murine host also proved successful with no difference in survival rate between these mice and mice transplanted with donor RBCs. 

The group have created an immortal RBC line which through testing, matches in-vitro and normal RBCs in all categories tested. The discovery could provide a reliable and suitable blood source for those with rare blood groups and those requiring regular transfusions. Although more work will need to be done before clinical use, the ability to create RBCs through an immortal line could help alleviate the pressure of securing blood donors for patients and could prove life-changing for many.  

Read the full paper here